home / stock / cbio / cbio news


CBIO News and Press, Catalyst Biosciences Inc. From 08/15/22

Stock Information

Company Name: Catalyst Biosciences Inc.
Stock Symbol: CBIO
Market: NASDAQ
Website: catalystbiosciences.com

Menu

CBIO CBIO Quote CBIO Short CBIO News CBIO Articles CBIO Message Board
Get CBIO Alerts

News, Short Squeeze, Breakout and More Instantly...

CBIO - Catalyst Biosciences GAAP EPS of $1.64

Catalyst Biosciences press release ( NASDAQ: CBIO ): Q2 GAAP EPS of $1.64. At the end of the second quarter, the Board expected the total amount of cash to be distributed to stockholders to be up to $65.0 million in one or more distributions Cash and cash equivalents a...

CBIO - Catalyst Biosciences Reports Second Quarter 2022 Operating & Financial Results

SOUTH SAN FRANCISCO, Calif., Aug. 15, 2022 (GLOBE NEWSWIRE) -- Catalyst Biosciences, Inc. (NASDAQ: CBIO) (the “Company” or “we”) today announced its operating and financial results for the second quarter ended June 30, 2022. “We were very pleased to ...

CBIO - Catalyst Biosciences: Shareholders Should Reap Benefits From Owning The Stock

Catalyst Biosciences is highly committed to its cash distribution plan to shareholders of up to $65 million in the near future, with only a $58 million market capitalization. If the proxy contest is cleared up between Catalyst and JDS1 and goes in favor of the executives of Catalyst, ...

CBIO - JDS1, LLC Terminates Proxy Contest at Catalyst's 2022 Annual Meeting

JDS1, LLC (“JDS1”), which collectively with the other reporting persons in its Section 13(d) group, beneficially owns approximately 8.4% of the outstanding common stock of Catalyst Biosciences, Inc. (NASDAQ: CBIO) (“Catalyst” or the “Company&#x...

CBIO - Catalyst Biosciences Announces Withdrawal of JDS1 Nominations to the Board

SOUTH SAN FRANCISCO, Calif., Aug. 10, 2022 (GLOBE NEWSWIRE) -- Catalyst Biosciences, Inc. (NASDAQ: CBIO) (the “Company,” “Catalyst” or “we”) announced that it has received a notice from JDS1, LLC (“JDS1”) that JDS1 has withdrawn the no...

CBIO - Leading Independent Proxy Advisory Firms ISS and Glass Lewis Recommend Catalyst Stockholders Vote "FOR" All of the Company's Nominees on the WHITE Proxy Card

ISS and Glass Lewis Highlight That Stockholders Are Best Served by Allowing the Incumbent Board to Pursue Its Cash Distribution Plan Catalyst Urges Stockholders to VOTE “FOR” All of the Company’s Nominees SOUTH SAN FRANCISCO, Calif., Aug. 03, 2022 (GLOBE NEW...

CBIO - Catalyst Biosciences Publishes New Investor Presentation

Provides Details on Current Board’s Cash Distribution Plan and Efforts to Maximize the Amount of Cash Available for Distribution Company Commits to Distributing $45 Million to Stockholders in an Initial Distribution, if Proxy Contest and Litigation End Soon, and Without M...

CBIO - Catalyst Biosciences Announces Support from Largest Single Stockholder

JEC Capital Partners Agrees to Vote Its Shares in Favor of Catalyst’s Nominees at the Company’s 2022 Annual Meeting Michael Torok from JEC Appointed as an Observer to the Transaction Committee of the Board of Directors Company Has Committed to Announcing a ...

CBIO - Catalyst Biosciences Sends Letter to Stockholders

Reiterates the Board’s Commitment to Expeditiously Distributing All of the Company’s Available Cash to Stockholders, Net of Liabilities and Obligations Warns Stockholders that JDS1 May Have Ulterior Motives in Running a Proxy Contest: Gaining Control of the Company...

CBIO - Catalyst Biosciences Comments on Favorable Delaware Court of Chancery Ruling

Court Denies JDS1’s Motion for Expedited Proceedings Board Reiterates Commitment to Distributing Cash to Stockholders Once Potential Liability and Expenses Associated with Stockholder Litigation and Proxy Contest Are Known SOUTH SAN FRANCISCO, Calif., July 06, 2022 ...

Previous 10 Next 10